Suppr超能文献

减毒联合疗法:一种治疗囊性纤维化患者感染的潜在多靶点协同方法。

Virulence attenuating combination therapy: a potential multi-target synergy approach to treat infections in cystic fibrosis patients.

作者信息

Shaw Elana, Wuest William M

机构信息

Department of Chemistry , Emory University , 1515 Dickey Drive , Atlanta , Georgia 30322 , USA . Email:

Emory Antibiotic Resistance Center , Emory University School of Medicine , 201 Dowman Drive , Atlanta , Georgia 30322 , USA.

出版信息

RSC Med Chem. 2020 Feb 19;11(3):358-369. doi: 10.1039/c9md00566h. eCollection 2020 Mar 1.

Abstract

The World Health Organization considers the discovery of new treatments for a top priority. Virulence attenuating combination therapy (VACT) is a pragmatic strategy to improve bacterial clearance, repurpose outmoded antibiotics, improve drug efficacy at lower doses, and reduce the evolution of resistance. and studies have shown that adding a quorum sensing inhibitor or an extracellular polymeric substance repressor to classical antibiotics synergistically improves antipseudomonal activity. This review highlights why VACT could specifically benefit cystic fibrosis patients harboring chronic infections, outlines the current landscape of synergistic combinations between virulence-targeting small-molecules and anti-pseudomonal drugs, and suggests future directions for VACT research.

摘要

世界卫生组织将发现新的治疗方法视为首要任务。减毒联合疗法(VACT)是一种切实可行的策略,可提高细菌清除率、重新利用过时的抗生素、在较低剂量下提高药物疗效并减少耐药性的产生。并且研究表明,在传统抗生素中添加群体感应抑制剂或细胞外聚合物阻遏物可协同提高抗假单胞菌活性。本综述强调了VACT为何能特别惠及患有慢性感染的囊性纤维化患者,概述了靶向毒力的小分子与抗假单胞菌药物之间协同组合的现状,并提出了VACT研究的未来方向。

相似文献

2
Oral anti-pseudomonal antibiotics for cystic fibrosis.用于囊性纤维化的口服抗假单胞菌抗生素。
Cochrane Database Syst Rev. 2016 Jul 14;7(7):CD005405. doi: 10.1002/14651858.CD005405.pub4.
8
Oral anti-pseudomonal antibiotics for cystic fibrosis.用于囊性纤维化的口服抗假单胞菌抗生素。
Cochrane Database Syst Rev. 2013 Oct 29(10):CD005405. doi: 10.1002/14651858.CD005405.pub3.

引用本文的文献

7
: Infections, Animal Modeling, and Therapeutics.感染、动物模型与治疗学
Cells. 2023 Jan 3;12(1):199. doi: 10.3390/cells12010199.
10
Quorum Sensing Inhibitors to Quench Pathogenicity.群体感应抑制剂以消除致病性。
Pharmaceuticals (Basel). 2021 Dec 5;14(12):1262. doi: 10.3390/ph14121262.

本文引用的文献

8
Evolution of the quorum-sensing hierarchy.群体感应调控层级的进化。
Proc Natl Acad Sci U S A. 2019 Apr 2;116(14):7027-7032. doi: 10.1073/pnas.1819796116. Epub 2019 Mar 8.
9
Itaconimides as Novel Quorum Sensing Inhibitors of .异戊烯酰胺类作为群体感应抑制剂的新型研究
Front Cell Infect Microbiol. 2019 Jan 7;8:443. doi: 10.3389/fcimb.2018.00443. eCollection 2018.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验